| Tag | Content |
|---|
EnhancerAtlas ID | HS018-00933 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr1:90189310-90191340 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Myog | MA0500.1 | chr1:90189602-90189613 | GACAGCTGCAG | + | 6.62 | | STAT1 | MA0137.3 | chr1:90190639-90190650 | TTTCTAGGAAA | + | 6.14 | | Tcf12 | MA0521.1 | chr1:90189602-90189613 | GACAGCTGCAG | + | 6.14 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09431 | chr1:90181698-90192468 | CD14 | | SE_38611 | chr1:90182889-90191593 | HUVEC |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I089723 | chr1 | 90188924 | 90191693 |
|
Enhancer Sequence | TGCAATTAAT ATTTCCATGT AACAAACCAG CCCAAAACTT AGCGGTGTAA AGCAACTACA 60
TTATAACACT CAGATTCTGT AGGTAAGGAA TCTGGCACAG CAAAGACCTC TTACTTATGC 120
TCCATGATGT GTGGGACCTC AGTTGGCAAG ACTTAATGGC TAGGAGCTAC AATCATCTGG 180
AGGCGTCTTC ACTCCCATGT CTGGTGTTTG ATTCTAGCTG TTGGCAGGAA CCTCAGCTGG 240
GGCTATCAGC CATAGCAAAC CTTTCCATGC AGCCTGGGCT TCCTCCCAGC ATGACAGCTG 300
CAGGGTAGTC AGGCATCTTA CACAATAGCT TAGGGTCCAA AACAAGTATT CCAAAAGACA 360
AAAAGGATGC TGCATCATCT TTCATGGCCT GTCCTCGAAA GTCACATTCC TCACTTCTGC 420
CATGCTCTTA TTAGTTAAAA CAGTCATAAA TCTTGCCCCG TTTCGGAGCA GCGGCAGAGA 480
AGACACAGAA CCCACGTTTC AGTGGGAGAA GTGCCAGTGT CACATCTTAA GAATATGTGG 540
AACAGGAGTT ATTGTTGTAG CCATCTATGA AAAATACAAT CTGTCACACA ATCTCACACC 600
AAATTCTTCA ACCATGGAGC AGCACTTCTA AATGTTTTAC ATGTAAGGAC CTCTAACTCT 660
TTAATGTTTG CTAACATTTA TAGATAGGAA ATATAGGATG CATAGAGGCC AAGAAACACT 720
CATGAATTTC ATACAATCTT TCAGCATATC CAGTAATTAT TGTAGAAAAG CAGAAAATTT 780
ACAAACCTAG TGTTTTCATT TCTCCTTTTC TTTGGGCAAG CAGGGGGAAC CTGGCAGAAT 840
GCGTATTATG AATAGCTGCA AGAAAGCCAT CATTTCATTT TATTCCCTCT TTAAAATCAT 900
TATCTTTTTG ACAGGATTTC AATGAGGCAC TTTTACAAAT TTTGGTTAAC GCTCTTACTT 960
CTCCTAGTGT AAGCCAAAAT TTCCTAAATG CTCAGAGACG GGTGTGTACA CACACCTCTT 1020
GTCTATGACT TACACAAATG AATAAGAGGA AATGTCTCAT CAGTCTCTGT GGTGAAAATG 1080
TGGAGAGACC AGGGGTGGGG CCTTAGCCAA GCCCCTGAGC TTCCATTTTT ATCCCAGCAC 1140
AGAAGTGTGC TCAGGGCTCT AGCTTCCTGC CCTCCCCAGC CTGACCCTAG TGAAGGTTAC 1200
AAACCCTCCC AGTGACTGCA GGACAGGCAG TGAGGGCAGG TCTCTTGCCT CCTTGCTTTG 1260
TGGCAGCCTT CTCAGTTGGG TCACATCATT CTTCTAGATC AGGAGGAACA TTTAGGGGTT 1320
GGAAAAAGTT TTCTAGGAAA GAATTACTCA TGAGCAAAGG GACCAGAAAA GTCCCAGAGA 1380
TGTTCTTCAG CAGACAATTT AAACTAATGA CTCGCTGCTG GGCAGCCTGC CCTATAATGG 1440
CTGATGTAAA CTGTGTCTAT GTAATGCTGT ATTAAGATCT GCGTTCTCCC TCCAGCCTAC 1500
TAAATCTCCA AACCAAATCA TTGAGGGCTT GCGTCACTCA TGTTTAATCT TGTAAAATCC 1560
ACCAACACAT TTTGCTTGTT CAGAAAGAAT ATTCAATAGT TATGATCGTC CATGATAAGG 1620
TTGCAGTGCA GATGTCGAAC TGGAGTCTGT ATGTCCCCTA AGATTTAGAT GAAATTGGCT 1680
ATACCCCCAA GTCCACTGCC CTCCCTAAGG TTTCATAAGT TTCCAATGTG TTTACATTTT 1740
CAGGCCACTG ACTCTGAGCC TCAGTCTCTA TGGAACATCT TCCATTCATC AGCTCACCAT 1800
TGCTTAGGTT AGATCTCCAT TCTAGAGTTT GATCCCTGTT CTTCAGTAAA CCACTGCCCT 1860
CTTCCTGGAT CTCCCCCAGC ACTCACACTA GGTTTTTGTG CATTTTAGAA ACTTTATTGA 1920
AGGTTTGGAG AGACAGCAGA GCATTCATGA GAGCAGTGCA AGCTACTCTA AAACCCCATG 1980
TTTGTGAAAG CCATCCCCAT CTTCCCCCTC CCAGCCCTTC CGTCTTTTTC 2030
|
